Atomo Diagnostics Ltd Total Liabilities

Latest as of December 2025: AU$2.84 Million AUD ≈ $2.01 Million USD

Atomo Diagnostics Ltd total liabilities. Based on the latest financial reports, Atomo Diagnostics Ltd (AT1) has total liabilities worth AU$2.84 Million AUD (≈ $2.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Atomo Diagnostics Ltd to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Atomo Diagnostics Ltd (2017–2025)

Total liabilities of Atomo Diagnostics Ltd from 2017 to 2025. This chart illustrates how Atomo Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data.

Atomo Diagnostics Ltd Competitors by Total Liabilities

The table below lists competitors of Atomo Diagnostics Ltd ranked by their total liabilities.

Company Country Total Liabilities
HYDROGEN UTOPIA INT.-001
F:D60
Germany €1.11 Million
Yorkton Equity Group Inc
V:YEG
Canada CA$151.72 Million
Mont Royal Resources Ltd
AU:MRZ
Australia AU$382.34K
Nakoda Group of Industries Limited
NSE:NGIL
India Rs-289.63 Million
IP Group
LSE:IPO
UK GBX123.20 Million
Workspace Group PLC
LSE:WKP
UK GBX955.40 Million
Trinseo SA
NYSE:TSE
USA $3.85 Billion
Willamette Valley Vineyards Inc
NASDAQ:WVVI
USA $36.53 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Atomo Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Atomo Diagnostics Ltd assets under control.

Liquidity & Leverage Metrics

Atomo Diagnostics Ltd Total Liabilities Ratios Explained

Atomo Diagnostics Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.78 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.43 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.30 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Atomo Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Atomo Diagnostics Ltd (2017–2025)

The table below shows the annual total liabilities of Atomo Diagnostics Ltd from 2017 to 2025.

Year Total Liabilities Change
2025-06-30 AU$2.30 Million
≈ $1.63 Million
+77.81%
2024-06-30 AU$1.29 Million
≈ $915.87K
-23.11%
2023-06-30 AU$1.68 Million
≈ $1.19 Million
-6.90%
2022-06-30 AU$1.81 Million
≈ $1.28 Million
-15.96%
2021-06-30 AU$2.15 Million
≈ $1.52 Million
+32.80%
2020-06-30 AU$1.62 Million
≈ $1.15 Million
-85.94%
2019-06-30 AU$11.52 Million
≈ $8.15 Million
-8.88%
2018-06-30 AU$12.64 Million
≈ $8.95 Million
+6.97%
2017-06-30 AU$11.82 Million
≈ $8.36 Million
--

About Atomo Diagnostics Ltd

AU:AT1 Australia Medical Devices
Market Cap
$8.30 Million
AU$11.73 Million AUD
Market Cap Rank
#27368 Global
#1317 in Australia
Share Price
AU$0.01
Change (1 day)
+8.33%
52-Week Range
AU$0.01 - AU$0.04
All Time High
AU$0.57
About

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also offers HIV Rapid self-Test device; and digital health solutions. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.